Pharma Mar | PHM - Cost Of Sales


Pharma Mar reported EUR3.66M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Almirall EUR 191.5M 2.29M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 955M 503M Mar/2026
Organon & Co USD 677M 89M Mar/2026
Pharma Mar EUR 3.66M 116K Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026